Literature DB >> 8129032

Divergent expression of EtA and EtB receptors in response to cyclosporine in mesangial cells.

M Takeda1, S Iwasaki, S E Hellings, H Yoshida, T Homma, V Kon.   

Abstract

We examined the effects of cyclosporine (Cy) on preproendothelin-1 (prepro Et-1) and both Et receptors, A-type (EtA) and B-type (EtB), in rat glomerular mesangial cells. Cy at 10(-5) mol/L, the concentration relevant to tissue levels in vivo, increased mRNA for prepro Et-1 after both 1 and 3 hours to 183 +/- 14% (n = 8) and 147 +/- 12% (n = 9) of levels seen in control cells. A similar pattern was observed at a lower dose of Cy (10(-6) mol/L, the concentration relevant to plasma levels in vivo): at 1 hour, expression increased to 146 +/- 15% (n = 5); at 3 hours, expression was 159 +/- 25% (n = 8). Concomitant with these changes in expression of prepro Et-1 mRNA, the Et-1 protein nearly doubled at 3 hours. Both EtA and EtB mRNA were expressed in unstimulated mesangial cells and were affected differently by Cy. Little change was observed in the EtA mRNA. In contrast, EtB mRNA increased with Cy (10(-5) mol/L) up to 129 +/- 8% (n = 6) at 1 hour and 265 +/- 62% (n = 3) at 3 hours. A similar effect was seen with the lower dose of Cy: EtB expression increased to 129 +/- 9% (n = 6) of control value at 1 hour and 253 +/- 74% (n = 4) at 3 hours. These results indicate that Cy enhances expression of mRNA for prepro Et-1 and production of mature Et-1 by glomerular mesangial cells. Further, Cy has differential effects on EtA and EtB, affecting EtA minimally while markedly increasing the expression of EtB. These results constitute the first demonstration that Et receptor subtypes are modulated in a pathophysiological setting. The divergent modulation of EtA and EtB raises the possibility that there are differences in contribution of each of the receptor subtypes to pathophysiological mechanisms of Cy toxicity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8129032      PMCID: PMC1887079     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Cloning and expression of a cDNA encoding an endothelin receptor.

Authors:  H Arai; S Hori; I Aramori; H Ohkubo; S Nakanishi
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

2.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor.

Authors:  T Sakurai; M Yanagisawa; Y Takuwa; H Miyazaki; S Kimura; K Goto; T Masaki
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

3.  Stimulatory effect of cyclosporine A on endothelin secretion by a cultured renal epithelial cell line, LLC-PK1 cells.

Authors:  H Nakahama
Journal:  Eur J Pharmacol       Date:  1990-05-03       Impact factor: 4.432

4.  Role of endothelin in cyclosporine-induced glomerular dysfunction.

Authors:  V Kon; M Sugiura; T Inagami; B R Harvie; I Ichikawa; R L Hoover
Journal:  Kidney Int       Date:  1990-06       Impact factor: 10.612

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

6.  Ischaemia causes externalization of endothelin-1 binding sites in rat cardiac membranes.

Authors:  J J Liu; D J Casley; W G Nayler
Journal:  Biochem Biophys Res Commun       Date:  1989-11-15       Impact factor: 3.575

7.  Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity.

Authors:  A Fogo; S E Hellings; T Inagami; V Kon
Journal:  Kidney Int       Date:  1992-09       Impact factor: 10.612

8.  Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction.

Authors:  M J Sumner; T R Cannon; J W Mundin; D G White; I S Watts
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

9.  Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation.

Authors:  D M Pollock; T J Opgenorth
Journal:  Am J Physiol       Date:  1993-01

10.  Endothelin receptor subtypes are coupled to adenylate cyclase via different guanyl nucleotide-binding proteins in vasculature.

Authors:  S Eguchi; Y Hirata; T Imai; F Marumo
Journal:  Endocrinology       Date:  1993-02       Impact factor: 4.736

View more
  4 in total

Review 1.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 2.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 3.  Endothelin and its antagonists in hypertension: can we foresee the future?

Authors:  P Moreau; T J Rabelink
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

Review 4.  Endothelin-1 and the kidney--beyond BP.

Authors:  Neeraj Dhaun; David J Webb; David C Kluth
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.